drugset / Trial / NCT00479882

MK-0524B Lipid Study (MK-0524B-063)

NCT00479882

Phase 3 Completed 2414 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

This is a 20-week clinical trial in participants with primary hypercholesterolemia or mixed dyslipidemia to demonstrate the effect of MK-0524B compared to MK-0524A + Simvastatin on lipid values.

Timeline

Start
2007-06-15
Primary completion
2008-06-16
Completion
2008-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-0524B Unknown 1.8 g
Subject MK0524A Unknown 2 g
Subject Simvastatin Small molecule 20 mg
Subject Simvastatin Small molecule 40 mg